Cox analysis indicated that high NG2 expression can promote a 7.528 times greater risk of death occurrence (HR = 7.528; 95% CI: 1.475–38.415; p = 0.015), while the reduction in PDGFR-β expression levels generated a 209.874-fold increase in the risk of cancer recurrence (HR = 209.874; 95% CI: 4.743–9287.552; p = 0.006) (Table 2). Here, PDGFRB is linked to cancer.